Home › Metastatic Cancer › Colorado › Denver
Pag-aaral pangklinika para sa Metastatic Cancer sa Denver, CO
29 pag-aaral para sa Metastatic Cancer ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Denver (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Nagre-recruitPhase 1
- Sarah Cannon Research Institute at HealthOne, Denver
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Nagre-recruitPhase 1/2
- Rocky Mountain Cancer Center, Denver
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1
- SCRI at HealthOne, Denver
A Study of ASP3082 in Adults With Advanced Solid Tumors
Nagre-recruitPhase 1
- Denver HealthONE Drug Development Unit, Denver
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Nagre-recruitPhase 3
- Intermountain Health Cancer Center Saint Joseph, Denver
- Intermountain Health Saint Joseph Hospital - Research Office, Denver
- Intermountain Health Saint Joseph Hospital, Denver
- at 3 pa
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Nagre-recruitPhase 3
- Research Site, Denver
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Nagre-recruitPhase 2
- Saint Joseph Hospital - Cancer Centers of Colorado, Denver
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Nagre-recruitPhase 1/2
- University of Colorado Cancer Center, Denver
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Nagre-recruitPhase 3
- AdventHealth Medical Group - Porter, Denver
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Nagre-recruitPhase 3
- AdventHealth Medical Group - Porter, Denver
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Nagre-recruitPhase 1/2
- UCHealth Cherry Creek Medical Center, Denver
- Rocky Mountain Cancer Centers,LLP, Denver
Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Sarah Cannon Research Institute at HealthONE, Denver
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Clinical Study Site, Denver
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- Sarah Cannon Research Institute at HealthOne, Denver
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Nagre-recruitPhase 1/2
- Avenzo Therapeutics Recruiting Site, Denver
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Nagre-recruitPhase 1
- Sarah Cannon Research Institute Denver, Denver
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1
- Sarah Cannon Research Institute at HealthONE, Denver
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
Nagre-recruitPhase 1/2
- Crinetics Study Site, Denver
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Rocky Mountain Cancer Center, Denver
- Sarah Cannon Research Institute at HealthONE, Denver
A Study of PYX-201 in Advanced Solid Tumors
Nagre-recruitPhase 1
- SCRI - HealthOne Denver, Denver
CT-95 in Advanced Cancers Associated With Mesothelin Expression
Nagre-recruitPhase 1
- Context Investigational Site, Denver
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Nagre-recruitPhase 2/3
- The Melanoma & Skin Cancer Institute, Englewood · 6 mi ang layo
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- Sarah Cannon Research Institute (SCRI) at HealthONE, Denver
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
Nagre-recruitPhase 1
- Sarah Cannon Research Institute at HealthONE, Denver
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Sarah Cannon Research Institute at HealthONE, Denver
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1
- Sarah Cannon Research Institute at HealthONE, Denver
Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma
Nagre-recruitPhase 1/2
- Sarah Cannon Research Institute (SCRI) - Denver HealthONE Location, Denver
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Denver
ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)
Nagre-recruitPhase 1
- SCRI Denver Drug Development Unit, Denver
Pag-aaral para sa Metastatic Cancer sa ibang lungsod
- Houston, TX104 pag-aaral
- New York City, NY93 pag-aaral
- Nashville, TN70 pag-aaral
- Boston, MA63 pag-aaral
- Los Angeles, CA57 pag-aaral
- St. Louis, MO54 pag-aaral
- Arlington, VA53 pag-aaral
- Philadelphia, PA46 pag-aaral
- Chicago, IL45 pag-aaral
- San Antonio, TX44 pag-aaral
- Washington, DC43 pag-aaral
- Dallas, TX42 pag-aaral
Iba pang pag-aaral sa Denver
- Kanser sa Suso29 pag-aaral
- Non-Small Cell Lung Cancer27 pag-aaral
- Multiple Myeloma27 pag-aaral
- Colorectal Cancer23 pag-aaral
- Melanoma19 pag-aaral
- Kanser sa Prostate19 pag-aaral
- Kanser (lahat ng uri)18 pag-aaral
- Kanser sa Ovary16 pag-aaral
- Kanser sa Baga16 pag-aaral
- Kanser ng Endometrium15 pag-aaral
- Non-Hodgkin Lymphoma14 pag-aaral
- Kanser sa Pancreas13 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.